Clinicopathological Proficiency in the Diagnosis of Kaposi's Sarcoma

Table 2

Distribution by anatomical sites of Kaposi’s sarcoma: HIV-positive versus unknown serostatus.

Site	Males HIV positive 𝑛 (%)	Females HIV positive 𝑛 (%)	Total HIV positive 𝑛 (%)	Males HIV status unknown 𝑛 (%)	Females HIV status unknown 𝑛 (%)	Total HIV status unknown 𝑛 (%)
Head	7 (8.8)*	4 (7.0)*	11 (8.0)^†	9 (23.7)*	9 (24.3)*	18 (24.0)^†
Trunk	5 (6.3)	1 (1.8)	6 (4.4)	3 (7.9)		3 (4.0)
Upper limbs	4 (5.0)	1 (1.8)	5 (3.6)	3 (7.9)	3 (8.1)	6 (8.0)
Lower limbs	34 (42.5)	23 (40.3)	57 (41.6)	17 (44.7)	18 (48.6)	35 (46.7)
Perineal	1 (1.3)	4 (7.0)	5 (3.6)	1 (2.6)	2 (5.4)	3 (4.0)
Disseminated	29 (36.2)	24 (42.1)	53 (38.7)^†	5 (13.2)	5 (13.5)	10 (13.3)^†
Unknown	4 (4.8)**	20 (26.0)**	24 (14.9)**	14 (36.8)**	11 (22.9)**	25 (25.0)**
Total	84	77	161	52	48	100

*% of the total number of known anatomical sites; ** % of the total number of cases; † statistically significant 95% confidence intervals (CIs).